Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Zhonghua Nei Ke Za Zhi|July 21, 2009
[The prevalence of depression and anxiety in gastrointestinal out-patients of tertiary general hospitals in Beijing]Rong-huan Jiang, Xin Yu, Hong Ma, et al.
Journal of Microbiology and Biotechnology|June 5, 2009
Biosynthesis of 3-hydroxy-5-methyl-o-methyltyrosine in the saframycin/ safracin biosynthetic pathwayCheng-Yu Fu, Man-Cheng Tang, Chao Peng, et al.
Journal of Clinical Pharmacology|October 4, 2008
Pharmacokinetics and pharmacodynamics of vildagliptin in healthy Chinese volunteersPei Hu, Qi Yin, Fabienne Deckert, et al.
Journal of Clinical Pharmacology|July 28, 2007
Dose proportionality and the effect of food on vildagliptin, a novel dipeptidyl peptidase IV inhibitor, in healthy volunteersGangadhar Sunkara, Ron Sabo, Yibin Wang, et al.
World Journal of Gastroenterology|June 2, 2012
Prevalence of depressive and anxiety disorders in Chinese gastroenterological outpatientsXiao-Jing Li, Yan-Ling He, Hong Ma, et al.
Zhonghua Yi Xue Za Zhi|December 6, 2005
[The neuropsychological test battery for elderly people]Hai-bo Xue, Shi-fu Xiao, Chun-bo Li, et al.
Zhonghua Nei Ke Za Zhi|October 29, 2010
[Recognition of depression and related risk factors among non psychiatric doctors in tertiary general hospital outpatients in Beijing]Rong-huan Jiang, Wei-min Dang, Hong Ma, et al.
Current Medical Research and Opinion|October 13, 2007
Evaluation of the potential for steady-state pharmacokinetic interaction between vildagliptin and simvastatin in healthy subjectsSurya P Ayalasomayajula, Kiran Dole, Yan-Ling He, et al.
Clinical Pharmacokinetics|August 24, 2007
The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteersYan-Ling He, Brian M Sadler, Ron Sabo, et al.
Current Medical Research and Opinion|May 24, 2007
Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjectsYan-Ling He, Ron Sabo, Gilles-Jacques Riviere, et al.
Pageof 10